Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 2/20 | 1.00 |
| ▸ | GRM6 | O15303 | 2/20 | 1.00 |
| ▸ | GRM7 | Q14831 | 2/20 | 1.00 |
| ▸ | GRM4 | Q14833 | 2/20 | 1.00 |
| ▸ | GRIN2D | O15399 | 1/20 | 1.00 |
| ▸ | GRIN3B | O60391 | 1/20 | 1.00 |
| ▸ | GSR | P00390 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | GRIK1 | P39086 | 1/20 | 1.00 |
| ▸ | GRM5 | P41594 | 1/20 | 1.00 |
| ▸ | GRIA1 | P42261 | 1/20 | 1.00 |
| ▸ | GRIA2 | P42262 | 1/20 | 1.00 |
| ▸ | GRIA3 | P42263 | 1/20 | 1.00 |
| ▸ | SLC1A3 | P43003 | 1/20 | 1.00 |
| ▸ | SLC1A2 | P43004 | 1/20 | 1.00 |
| ▸ | SLC1A1 | P43005 | 1/20 | 1.00 |
| ▸ | GRIA4 | P48058 | 1/20 | 1.00 |
| ▸ | GRIN1 | Q05586 | 1/20 | 1.00 |
| ▸ | GRIN2A | Q12879 | 1/20 | 1.00 |
| ▸ | GRIK2 | Q13002 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutamic Acid SCHEMBL1554237 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| D-Glutamate SCHEMBL2201 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| D-Glutamate SCHEMBL1332297 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| D-Glutamate SCHEMBL1330484 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| Glutamic Acid SCHEMBL248800 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| D-Glutamate SCHEMBL931953 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| Glutamic Acid SCHEMBL5704264 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| D-Glutamate SCHEMBL1330824 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| D-Glutamate SCHEMBL17127348 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D | |
| D-Glutamate SCHEMBL1332144 | 1.00 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12515210-B2 | Regenerating the catalytic activity of a spent catalyst | TOPSOE A/S (DK) | 2026-01-06 | — | — | US | claimed |
| CN-114761637-B | Non-rewet O/W (oil-in-water) emulsifying system for hydrophobic compounds | 有机点击股份公司 | 2025-02-11 | — | — | CN | claimed |
| US-20250003152-A1 | CITRIC ACID-CATALYSED CURRAN MODIFIED CARD BOARD MATERIALS | CELLUCOMP LIMITED (GB) | 2025-01-02 | — | — | US | claimed |
| US-12170350-B2 | Lithium secondary battery including separator with ceramic layer having first ceramic particle bonded to second ceramic particle and manufacturing method the same | HYUNDAI MOTOR COMPANY (KR) | 2024-12-17 | — | — | US | claimed |
| EP-4426890-A1 | CITRIC ACID-CATALYSED CURRAN MODIFIED CARD BOARD MATERIALS | Cellucomp Limited (GB) | 2024-09-11 | — | — | EP | claimed |
| US-20240269152-A1 | NADES FORMULATIONS COMPRISING CANNABINOIDS | CLEMSON UNIVERSITY | 2024-08-15 | — | — | US | claimed |
| US-20240269141-A1 | NADES FORMULATIONS COMPRISING PHARMACEUTICALS | CLEMSON UNIVERSITY | 2024-08-15 | — | — | US | claimed |
| WO-2024128542-A1 | CUTTING OIL COMPOSITION | 와이씨켐 주식회사 | 2024-06-20 | — | — | WO | claimed |
| CN-115124642-B | Modified telechelic liquid rubber and preparation method thereof, wide-temperature-range low-heat-generation controllable viscosity rubber and preparation method thereof | 株洲时代新材料科技股份有限公司 | 2024-03-29 | — | — | CN | claimed |
| EP-3677706-B1 | COMPOSITIONS AND METHOD FOR PRE-TREATING SUBSTRATES FOR SUBSEQUENT FIXATION OF VAPOR PHASE CORROSION INHIBITORS | EXCOR KORROSIONSFORSCHUNG GMBH (DE) | 2024-03-06 | — | — | EP | claimed |
| US-20200170923-A1 | USE OF POLYCARBOXYLIC ACID COMPOUNDS FOR THE TREATMENT OF FIBRIOUS AMINO ACID BASED SUBSTRATES, ESPECIALLY HAIR | MOMENTIVE PERFORMANCE MATERIALS INC. | 2020-06-04 | — | — | US | claimed |
| WO-2019178141-A1 | ORGANIC METABOLITE COMPOSITIONS AND METHODS OF USE AS MITICIDES FOR HONEY BEES | NIEMCZURA PAUL (US) | 2019-09-19 | — | — | WO | claimed |
| US-9879293-B2 | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2018-01-30 | — | — | US | claimed |
| US-20160177354-A1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | SAFC, INC. | 2016-06-23 | — | — | US | claimed |
| EP-2462115-B1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | INFINITY PHARMACEUTICALS INC (US) | 2016-01-06 | — | — | EP | claimed |
| US-8703448-B2 | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2014-04-22 | — | — | US | claimed |
| EP-2462115-A1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | Infinity Pharmaceuticals, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| US-20120083607-A1 | Enzymatic Transamination of Cyclopamine Analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2012-04-05 | — | — | US | claimed |
| US-20110139713-A1 | METHOD OF TREATMENT FOR WASTE WATER USING MICROBIALGROWTH PROMOTER | NRP GROUP, INC. | 2011-06-16 | — | — | US | claimed |
| WO-2011017551-A1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | INFINITY PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269152-A1 | NADES FORMULATIONS COMPRISING CANNABINOIDS | CNR2, CNR1, NNT | GRM8 1016/4885GRM6 779/4885GRM7 1092/4885 |
| US-20120083607-A1 | Enzymatic Transamination of Cyclopamine Analogs | TKT, TALDO1, BCHE | GRM8 3695/4885GRM6 3773/4885GRM7 3798/4885 |
| US-20240269141-A1 | NADES FORMULATIONS COMPRISING PHARMACEUTICALS | NNT, NADK, NAPRT | GRM8 2568/4885GRM6 2228/4885GRM7 2439/4885 |
| US-20200170923-A1 | USE OF POLYCARBOXYLIC ACID COMPOUNDS FOR THE TREATMENT OF FIBRIOUS AMINO ACID BASED SUBSTRATES, ESPECIALLY HAIR | ABAT, PCCA, FH | GRM8 2934/4885GRM6 1965/4885GRM7 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.